GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
C56.1
Malignant neoplasm of right ovary
ICD10CM code
Medical Policies and Guidelines for Malignant neoplasm of right ovary
Related policies from health plans
ANTHEM-BLUECROSS-CA
Abraxane (paclitaxel, protein-bound)
ANTHEM-BLUECROSS-CA
BRCA Genetic Testing
ANTHEM-BLUECROSS-CA
Bevacizumab for Non-Ophthalmologic Indications
ANTHEM-BLUECROSS-CA
Docetaxel (Docefrez, Taxotere)
ANTHEM-BLUECROSS-CA
Doxorubicin Liposome (Doxil, Lipodox)
ANTHEM-BLUECROSS-CA
Elahere (mirvetuximab)
ANTHEM-BLUECROSS-CA
Elahere (mirvetuximab)
ANTHEM-BLUECROSS-CA
Ethyol (amifostine)
ANTHEM-BLUECROSS-CA
Ethyol (amifostine)
ANTHEM-BLUECROSS-CA
GNRH Analogs for Oncologic Indications
ANTHEM-BLUECROSS-CA
Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP), Attenuated
ANTHEM-BLUECROSS-CA
Human Chorionic Gonadotropin Testing
HEALTHFIRST
Pharmacogenetic Testing
ANTHEM-BLUECROSS-CA
Outpatient Alpha-Fetoprotein Testing
ANTHEM-BLUECROSS-CA
Pemetrexed Agents (Alimta, Pemfexy)
ANTHEM-BLUECROSS-CA
Pemetrexed Agents (Alimta, Pemfexy)
CIGNA
Low-Level Laser and High-Power Laser Therapy - (CPG030)
ANTHEM-BLUECROSS-CT
CG-GENE-16 BRCA Genetic Testing
ANTHEM-BLUECROSS-CT
CG-GENE-15 Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP), Attenuated FAP and MYH-associated Polyposis
ANTHEM-BLUECROSS-CT
CG-LAB-26 Outpatient Alpha-Fetoprotein Testing
ANTHEM-BLUECROSS-CT
CG-LAB-27 Human Chorionic Gonadotropin Testing
ANTHEM-BLUECROSS-CT
TRANS.00030 Hematopoietic Stem Cell Transplantation for Germ Cell Tumors
ANTHEM-BLUECROSS-CT
TRANS.00030 Hematopoietic Stem Cell Transplantation for Germ Cell Tumors
SUNFLOWER
ABRAXANE, Paclitaxel Protein-Bound Particles
SUNFLOWER
AVASTIN, Bevacizumab ZIRABEV MVASI
Similar Codes
ICD10CM codes
C56.1
- Malignant neoplasm of right ovary
C56.0
- Malignant neoplasm of right ovary
C56.2
- Malignant neoplasm of left ovary
C56
- Malignant neoplasm of ovary
C56.9
- Malignant neoplasm of unspecified ovary
C56.3
- Malignant neoplasm of bilateral ovaries
C79.61
- Secondary malignant neoplasm of right ovary
D27.0
- Benign neoplasm of right ovary
C57.01
- Malignant neoplasm of right fallopian tube
C79.62
- Secondary malignant neoplasm of left ovary
HCPCS codes
G9842
- Patient has metastatic disease at diagnosis
D7430
- Excision of benign tumor-lesion diameter up to 1.25 cm
G9097
- Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G0101
- Cervical or vaginal cancer screening; pelvic and clinical breast examination
G8875
- Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9552
- Incidental thyroid nodule < 1.0 cm noted in report
G9618
- Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial
G9613
- Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)
G9774
- Patients who have had a hysterectomy
C8906
- Magnetic resonance imaging with contrast, breast; bilateral
CPT4 codes
58900
- Biopsy of ovary, unilateral or bilateral (separate procedure)
58956
- Bilateral salpingo-oophorectomy with total omentectomy, total abdominal hysterectomy for malignancy
58951
- Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oopho
58950
- Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oopho
58925
- Ovarian cystectomy, unilateral or bilateral
58825
- Transposition, ovary(s)
43611
- Excision, local; malignant tumor of stomach
58958
- Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (int
58957
- Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (int
58952
- Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oopho